EagleClaw Capital Managment, LLC

Position in REPL — Replimune Group, Inc.

CIK 1607636 BOSTON, MA

Position in REPL

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$110,700

New position

Shares Held

10,000

first reported quarter

Ownership

0.011%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#132

of 198 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EagleClaw Capital Managment, LLC holds $4,783,467 across 3 Biotechnology names. REPL ranks #3 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	7,535	$3,742,860
2	CRSP	CRISPR Therapeutics AG	17,050	$929,907
3	REPL	Replimune Group, Inc. This page	10,000	$110,700

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$110,700	10,000	—	Shares	Sole	2026-08-10
No filing history on record for this holder in this stock.